Elicio Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1,166 | $0 | $0 | $0 |
Gross Profit | 583 | -293 | -290 | |
EBITDA | -13,465 | -10,344 | -6,887 | -11,501 |
EBIT | -13,770 | -10,634 | -7,180 | -11,791 |
Net Income | -14,004 | -18,838 | -7,229 | -11,827 |
Net Change In Cash | 1,166 | 0 | 0 | 0 |
Free Cash Flow | -5,595 | -7,274 | -12,122 | -12,122 |
Cash | 17,618 | 26,016 | 3,821 | 11,853 |
Basic Shares | 12,202 | 13,582 | 11,284 | 10,273 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $28,312 |
Gross Profit | -1,170 | -1,057 | 27,078 | |
EBITDA | -44,986 | -32,966 | -23,554 | -51,925 |
EBIT | -52,353 | -34,136 | -24,611 | -52,726 |
Net Income | -51,898 | -35,195 | -28,207 | -26,400 |
Net Change In Cash | 0 | 0 | 0 | 28,312 |
Free Cash Flow | -37,155 | -32,760 | -22,832 | -24,464 |
Cash | 17,618 | 12,894 | 6,155 | 9,278 |
Basic Shares | 12,202 | 5,056 | 3,100 | 3,200 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$1.26 |
2024-12-31 | -$1.02 |
2024-09-30 | -$1.39 |
2024-06-30 | -$0.64 |
